{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:26:34Z","timestamp":1789179994337,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.breast.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T02:34:17Z","timestamp":1650594857000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ"],"prefix":"10.1016","volume":"64","author":[{"given":"Farbod","family":"Darvishian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Axelrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Roses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.breast.2022.04.004_bib1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41379-018-0030-x","article-title":"Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?","volume":"31","author":"Agahozo","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.breast.2022.04.004_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-016-4036-0","article-title":"Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast","volume":"161","author":"Campbell","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2022.04.004_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-009-0654-0","article-title":"Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ","volume":"123","author":"Sharma","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2022.04.004_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdw623","article-title":"The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast","volume":"28","author":"Pruneri","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.breast.2022.04.004_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1218106","article-title":"The ratio of CD8+\/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ","volume":"5","author":"Semeraro","year":"2016","journal-title":"OncoImmunology"},{"issue":"10","key":"10.1016\/j.breast.2022.04.004_bib6","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1245\/s10434-019-07562-x","article-title":"Tumor-infiltrating lymphocytes in a contemporary cohort of women with ductal carcinoma in situ (DCIS)","volume":"26","author":"Darvishian","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2022.04.004_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.breast.2022.04.004_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"issue":"6024","key":"10.1016\/j.breast.2022.04.004_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.breast.2022.04.004_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JOP.777003","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"6","author":"Hammond","year":"2010","journal-title":"J Oncol Pract"},{"issue":"20","key":"10.1016\/j.breast.2022.04.004_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2022.04.004_bib12","series-title":"R: a language and environment for statistical computing","year":"2013"},{"issue":"8","key":"10.1016\/j.breast.2022.04.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v061.i08","article-title":"Optimal Cutpoints: an R package for selecting optimal cutpoints in diagnostic tests","volume":"61","author":"Lopez-Raton","year":"2014","journal-title":"J Stat Software"},{"key":"10.1016\/j.breast.2022.04.004_bib14","series-title":"A package for survival analysis in R. R package version 3.2-7","author":"Therneau","year":"2020"},{"key":"10.1016\/j.breast.2022.04.004_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"Medrek","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2022.04.004_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.breast.2022.04.004_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00428-019-02735-1","article-title":"Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence","volume":"476","author":"Chen","year":"2020","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.breast.2022.04.004_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jclinpath-2011-200355","article-title":"Tumour-infiltrating macrophages and clinical outcome in breast cancer","volume":"65","author":"Mahmoud","year":"2012","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.breast.2022.04.004_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.breast.2022.04.004_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10549-012-2405-x","article-title":"Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages","volume":"137","author":"Alkhateeb","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.breast.2022.04.004_bib21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2022.04.004_bib22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","article-title":"Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients","volume":"25","author":"Ali","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.breast.2022.04.004_bib23","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/cam4.715","article-title":"CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous \"healing\" in HER2-positive ductal carcinoma in situ","volume":"5","author":"Morita","year":"2016","journal-title":"Cancer Med"},{"issue":"34","key":"10.1016\/j.breast.2022.04.004_bib24","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:44:48Z","timestamp":1760777088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"alternative-id":["S0960977622000777"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.04.004","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}